⭐ Recognized by FeedSpot: #12 Best Anesthesiology Blog Worldwide

Anesthesiology Published - 1 October, 2025    By - Dr Clemens
How ASCs can keep anesthesia sustainable

Author: Francesca Mathewes Becker’s ASC Review Amid mounting reimbursement pressures and rising operational costs, ASC leaders are looking to models for managing anesthesia costs and staffing that will sustain them into the future. Peter Bravos, MD, chief medical officer of Sacramento, Calif.-based Sutter Health’s surgery center division, recently joined Becker’s to discuss the ways that ASCs can […]

Read More
Anesthesiology Published - 1 October, 2025    By - Dr Clemens
Remimazolam in neuroanesthesia

Author: Abramovich I et al. Current Opinion in Anesthesiology 38(5):547–552, October 2025. doi:10.1097/ACO.0000000000001524 This review examines remimazolam—an ultrashort-acting benzodiazepine—in neuroanesthesia. Across recent RCTs and case reports, remimazolam generally produced fewer hypotensive episodes, reduced vasopressor requirements, and allowed faster emergence, especially when flumazenil was used. However, higher BIS values at comparable sedation levels raise monitoring accuracy […]

Read More
Anesthesiology Published - 1 October, 2025    By - Dr Clemens
Metabolic alkalosis acquired in intensive care

Author: Goh G et al. Anaesthesia Critical Care & Pain Medicine, 2025. doi:10.1016/j.accpm.2025.101591 This multicenter retrospective cohort from 12 Queensland ICUs (2015–2021) evaluated ICU-acquired metabolic alkalosis. Among 24,676 eligible adult admissions (ICU LOS >48 h; no alkalosis in first 24 h), 36% (n=8,889) developed alkalosis, typically on day 4 (IQR 3–6). Diuretics (28%) and steroids […]

Read More
Anesthesiology Published - 1 October, 2025    By - Dr Clemens
Private equity and anesthesia: 8 notes

Author: Francesca Mathewes Becker’s ASC Review Private equity’s presence in anesthesia has been the subject of several recent lawsuits and studies on healthcare costs as the specialty becomes increasingly consolidated. Here are eight notes private equity group’s recent moves in anesthesia: 1. A study published in July by the University of Chicago’s Booth School of Business found that anesthesia costs […]

Read More
Anesthesiology Published - 1 October, 2025    By - Dr Clemens
TEG® 6s heparin neutralization cartridge for hemostatic assessment of patients undergoing cardiovascular surgery

Author: Adelmann D et al. Anesthesiology, September 18, 2025. doi:10.1097/ALN.0000000000005759 This multicenter observational study evaluated the TEG® 6s Global Hemostasis – Heparin Neutralization cartridge, newly cleared by the FDA, in patients undergoing cardiovascular surgery with cardiopulmonary bypass (CPB) or other invasive cardiac procedures requiring unfractionated heparin. A total of 543 blood samples from 185 patients […]

Read More